SYNTHESIS AND IN-VIVO ANTITUMOR-ACTIVITY OF NEW HETEROCYCLIC-DERIVATIVES OF THE 1,3,4-THIADIAZOLIUM-2-AMINIDE CLASS

Citation
N. Grynberg et al., SYNTHESIS AND IN-VIVO ANTITUMOR-ACTIVITY OF NEW HETEROCYCLIC-DERIVATIVES OF THE 1,3,4-THIADIAZOLIUM-2-AMINIDE CLASS, Anti-cancer drugs, 8(1), 1997, pp. 88-91
Citations number
13
Categorie Soggetti
Oncology,"Pharmacology & Pharmacy
Journal title
ISSN journal
09594973
Volume
8
Issue
1
Year of publication
1997
Pages
88 - 91
Database
ISI
SICI code
0959-4973(1997)8:1<88:SAIAON>2.0.ZU;2-B
Abstract
Four new mesoionic compounds derivates of -(4-X-cinnamoyl)-1,3,4-thiad iazalium-2-phenylamine chlorides were synthesized and their antitumor activities against Ehrlich carcinoma and Sarcoma 180 (S180) were evalu ated. In the schedule assayed, the derivatives where X = OH and X = NO 2 injected i.p. in mice at a total dose level of 10 and 30 mg/kg respe ctively caused a significant inhibition of ascitic S180 growth, and at a dose of 25 mg/kg inhibited the growth of Ehrlich carcinoma. The der ivatives where X = H and X = OCH3 did not show activity. There are no significant changes of hematopoietic parameters of the derivatives in this treatment These data suggest that the presence of more polar subs tituents, NO2 and OH, strongly increases the antitumor activity of thi s class of compounds.